Table 4.
Number of available specimens for each tumor class and combination of genomic measurement platforms
| Number of specimens | Analysis platform | |||
|---|---|---|---|---|
|
| ||||
| Primary | Metastatic | Total | RNA-seq | miRNA-seq |
| 88 | 338 | 426 | ✓ | ✓ |
| 6 | 16 | 22 | ✓ | |
| 10 | 13 | 23 | ✓ | |
|
| ||||
| Platform-specific primary | 94 | 98 | ||
| Platform-specific metastatic | 354 | 351 | ||
| Platform-specific overall | 448 | 449 | ||